ctrl K

AI Score

Unlock

Intensity Therapeutics In... (INTS)

AI Score

Unlock

2.35

0.09 (3.98%)

At close: Feb 28, 2025, 3:59 PM

2.34

-0.43%

After-hours: Feb 28, 2025, 04:00 PM EST

Intensity Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	147K	179.04K	n/a	n/a	n/a
Gross Profit	-147K	-179.04K	n/a	n/a	n/a
Operating Income	-8.32M	-7.63M	-8.01M	-6.22M	-5.68M
Interest Income	324K	2.48K	2.61K	74.01K	150.71K
Pretax Income	-10.54M	-7.58M	-7.9M	-6.03M	-5.38M
Net Income	-10.54M	-7.45M	-7.89M	-5.96M	-5.23M
Selling & General & Admin	3.39M	2.42M	2.16M	1.17M	1.24M
Research & Development	4.79M	5.13M	5.86M	5.05M	4.44M
Other Expenses	n/a	47.65K	115.51K	118.76K	144.99K
Operating Expenses	8.17M	7.55M	8.01M	6.22M	5.68M
Interest Expense	305K	81.78K	16.77K	n/a	n/a
Selling & Marketing Expenses	-147K	n/a	n/a	n/a	n/a
Cost & Expenses	8.32M	7.55M	8.01M	6.22M	5.68M
Income Tax	n/a	-131.91K	-2.61K	-74.01K	-150.71K
Shares Outstanding (Basic)	8.62M	13.1M	13.1M	13.1M	13.1M
Shares Outstanding (Diluted)	8.62M	13.1M	13.1M	13.1M	13.1M
EPS (Basic)	-1.38	-0.57	-0.6	-0.45	-0.4
EPS (Diluted)	-1.38	-0.57	-0.6	-0.45	-0.4
EBITDA	-10.09M	-7.4M	-7.88M	-6.03M	-5.38M
Depreciation & Amortization	147K	179.04K	236.56K	206.3K	171.86K